| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 | Jun'17 |
|---|---|---|---|---|---|---|---|---|---|---|
Operating expenses | ||||||||||
Research and development | ||||||||||
65,045 | 61,858 | 56,307 | 48,946 | 41,984 | 33,287 | 27,589 | 22,641 | 0 | 0 | 0 |
General and administrative | ||||||||||
35,319 | 29,560 | 23,774 | 19,526 | 15,955 | 12,434 | 8,852 | 6,423 | 0 | 0 | 0 |
Total operating expenses | ||||||||||
100,364 | 91,418 | 80,081 | 68,472 | 57,939 | 45,721 | 36,441 | 29,064 | 0 | 0 | 0 |
Loss from operations | ||||||||||
-100,364 | -91,418 | -80,081 | -68,472 | -57,939 | -45,721 | -36,441 | -29,064 | 0 | 0 | 0 |
Interest income, net | ||||||||||
7,160 | 6,201 | 4,911 | 3,860 | 3,181 | 2,375 | 773 | -136 | 0 | 0 | 0 |
Other income (expense), net | ||||||||||
-39 | -155 | -115 | -89 | -248 | -192 | -228 | -240 | 0 | 0 | 0 |
Loss before benefit from income taxes | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | - |
Provision for (benefit from) income taxes | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | - |
Net loss | ||||||||||
-93,243 | -85,372 | -75,285 | -64,701 | -55,006 | -43,538 | -34,930 | -28,474 | 0 | 0 | 0 |
Unrealized gain on marketable securities, net of tax | ||||||||||
1,976 | 152 | 135 | 111 | 30 | -15 | -33 | 0 | 0 | 0 | - |
Comprehensive loss | ||||||||||
-91,267 | -85,220 | -75,150 | -64,590 | -54,976 | -43,553 | -34,963 | -28,471 | 0 | 0 | 0 |
Net loss per common share: | ||||||||||
Basic and diluted | ||||||||||
-0.57 | -0.51 | -0.47 | -0.44 | -0.47 | 6.50 | -0.34 | -4.17 | -4.19 | -3.60 | -3.18 |
Weighted-average number of common shares outstanding: | ||||||||||
Basic and diluted | ||||||||||
48,691 | 48,749 | 46,280 | 43,115 | 42,620 | 42,451 | 32,609 | 2,248 | 2,024 | 1,643 | 1,477 |